Vedanta Biosciences Highlights Advances in Microbiome-Based Therapeutics at ESCMID 2026 Global Congress Vedanta Biosciences, a late clinical-stage biopharmaceutical company focused on developing microbiome-based oral therapies for gastrointestinal diseases, has announced…
Charles River Promotes Cardiovascular Health Awareness with Support for the American Heart Association Charles River Laboratories International, Inc. (NYSE: CRL) has announced a new collaboration with the American Heart Association,…
Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer, Strengthening Leadership with Multimedia Announcement Byondis B.V., an independent biotechnology company focused on the development of innovative targeted therapies for…
Emalex Awarded U.S. Patent for Its Orally Disintegrating Ecopipam Formulation Emalex Biosciences has announced a significant advancement in its drug development efforts with the issuance of a new patent by…
A Significant Proportion of Adults in the Community May Be Unaware They Are Living with Prediabetes The El Camino Healthcare District has launched a comprehensive new initiative aimed at tackling…
Cartherics and Catalent Extend Scope of Existing Commercial Licensing Agreement Cartherics Pty Ltd, a clinical-stage biotechnology company focused on developing next-generation immune cell therapies for high-impact women’s health conditions, has…
Fresenius Kabi Receives CMS Approval for COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg) Fresenius Kabi, a subsidiary of Fresenius and a global leader in essential medicines and medical technologies, has…
Join over 1,000 emergency medicine professionals from across the globe at the Annual Conference 2026, taking place in Birmingham on 28–30 April, as we come together to shape the future of the specialty. With a…
Cosette Pharmaceuticals Broadens Branded Portfolio with Acquisition of SYMPAZAN® and Additional Assets from Assertio Cosette Pharmaceuticals has announced the successful closing of a strategic acquisition that significantly expands its branded…
Assertio Enters Definitive Agreement for Acquisition by Garda Therapeutics Assertio Holdings Inc. has announced a transformative set of transactions that will significantly reshape the company’s structure and deliver immediate value…
TAE Life Sciences Highlights Breakthrough BNCT Research Showing Sustained Tumor Control and Systemic Immune Effects TAE Life Sciences has announced the publication of new preclinical research in ACS Pharmacology &…
Pilatus Biosciences to Showcase New Data on Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 Pilatus Biosciences has announced that it will present new preclinical findings at…